SEARCH

SEARCH BY CITATION

References

  • Anastas JN, Biechele TL, Robitaille M, Muster J, Allison KH, Angers S, Moon RT (2011) A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression. Oncogene 31: 3696- 3708
  • Augustin I, Goidts V, Bongers A, Kerr G, Vollert G, Radlwimmer B, Hartmann C, Herold-Mende C, Reifenberger G, Deimling von A, et al (2011) The Wnt secretion protein Evi/Gpr177 promotes glioma tumourigenesis. EMBO Mol Med 4: 38- 51
  • Bachmann IM (2005) Importance of P-cadherin, β-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Clin Cancer Res 11: 8606- 8614
  • Belenkaya TY, Wu Y, Tang F, Zhou B, Cheng L, Sharma Y, Yan D, Selva E, Lin X (2008) The retromer complex influences Wnt secretion by recycling Wntless from endosomes to the trans-golgi network. Dev Cell 14: 120- 131
  • Biechele TL, Moon RT (2008) Assaying β-catenin/TCF transcription with β-catenin/TCF transcription-based reporter constructs. Methods Mol Biol 468: 99- 110
  • Biechele TL, Kulikauskas RM, Toroni RA, Lucero OM, Swift RD, James RG, Robin NC, Dawson DW, Moon RT, Chien AJ (2012) Wnt/β-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma. Sci Signal 5: ra3
  • Cawthorn WP, Bree AJ, Yao Y, Du B, Hemati N, Martinez-Santibañez G, Macdougald OA (2011) Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate osteoblastogenesis through a β-catenin-dependent mechanism. Bone 50: 477- 489
  • Cheng S-L, Shao J-S, Cai J, Sierra OL, Towler DA (2008) Msx2 exerts bone anabolism via canonical Wnt signaling. J Biol Chem 283: 20505- 20522
  • Chien AJ, Conrad WH, Moon RT (2009a) A Wnt survival guide: from flies to human disease. J Investig Dermatol 129: 1614- 1627
  • Chien AJ, Moore EC, Lonsdorf AS, Kulikauskas RM, Rothberg BG, Berger AJ, Major MB, Hwang ST, Rimm DL, Moon RT (2009b) Activated Wnt/β-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc Natl Acad Sci 106: 1193- 1198
  • Clevers H, Nusse R (2012) Wnt/β-catenin signaling and disease. Cell 149: 1192- 1205
  • Coombs GS, Yu J, Canning CA, Veltri CA, Covey TM, Cheong JK, Utomo V, Banerjee N, Zhang ZH, Jadulco RC, et al (2010) WLS-dependent secretion of WNT3A requires Ser209 acylation and vacuolar acidification. J Cell Sci 123: 3357- 3367
  • Damsky WE, Curley DP, Santhanakrishnan M, Rosenbaum LE, Platt JT, Gould Rothberg BE, Taketo MM, Dankort D, Rimm DL, McMahon M, et al (2011) β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas. Cancer Cell 20: 741- 754
  • De Panfilis G, Ferrari D, Santoro S, Ricci R, Lombardi M, Pedrazzi G, Pepe C, Cortelazzi C, Santini M (2009) Cytoplasmic β-catenin is lacking in a subset of melanoma-associated naevi, but is detectable in naevus-associated melanomas: potential implications for melanoma tumorigenesis? Br J Dermatol 160: 600- 608
  • Delmas V, Beermann F, Martinozzi S, Carreira S, Ackermann J, Kumasaka M, Denat L, Goodall J, Luciani F, Viros A, et al (2007) Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes Dev 21: 2923- 2935
  • Dorsky RI, Moon RT, Raible DW (1998) Control of neural crest cell fate by the Wnt signalling pathway. Nature 396: 370- 373
  • Fu J, Jiang M, Mirando AJ, Yu H-MI, Hsu W (2009) Reciprocal regulation of Wnt and Gpr177/mouse Wntless is required for embryonic axis formation. Proc Natl Acad Sci 106: 18598- 18603
  • Gould Rothberg BE, Berger AJ, Molinaro AM, Subtil A, Krauthammer MO, Camp RL, Bradley WR, Ariyan S, Kluger HM, Rimm DL (2009) Melanoma prognostic model using tissue microarrays and genetic algorithms. J Clin Oncol 27: 5772- 5780
  • Graells J, Vinyals A, Figueras A, Llorens A, Moreno A, Marcoval J, Gonzalez FJ, Fabra A (2004) Overproduction of VEGF concomitantly expressed with its receptors promotes growth and survival of melanoma cells through MAPK and PI3K signaling. J Invest Dermatol 123: 1151- 1161
  • Haqq C, Nosrati M, Sudilovsky D, Crothers J, Khodabakhsh D, Pulliam BL, Federman S, Miller JR, Allen RE, Singer MI, et al (2005) The gene expression signatures of melanoma progression. Proc Natl Acad Sci USA 102: 6092- 6097
  • Harterink M, Port F, Lorenowicz MJ, McGough IJ, Silhankova M, Betist MC, van Weering JRT, van Heesbeen RGHP, Middelkoop TC, Basler K, et al (2011) A SNX3-dependent retromer pathway mediates retrograde transport of the Wnt sorting receptor Wntless and is required for Wnt secretion. Nat Cell Biol 13: 914- 923
  • Hattermann K, Held-Feindt J, Mentlein R (2011) Spheroid confrontation assay: a simple method to monitor the three-dimensional migration of different cell types in vitro. Ann Anat 193: 181- 184
  • Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat J-P, Nickerson E, Auclair D, Li L, Place C, et al (2012) A landscape of driver mutations in melanoma. Cell 150: 251- 263
  • Huang S-MA, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA, Charlat O, Wiellette E, Zhang Y, Wiessner S, et al (2009) Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461: 614- 620
  • Jho E-H, Zhang T, Domon C, Joo C-K, Freund J-N, Costantini F (2002) Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22: 1172- 1183
  • Kageshita T, Hamby CV, Ishihara T, Matsumoto K, Saida T, Ono T (2001) Loss of β-catenin expression associated with disease progression in malignant melanoma. Br J Dermatol 145: 210- 216
  • Kozlowski JM, Fidler IJ, Campbell D, Xu ZL, Kaighn ME, Hart IR (1984) Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 44: 3522- 3529
  • Larue L, Kumasaka M, Goding CR (2003) Beta-catenin in the melanocyte lineage. Pigment Cell Res 16: 312- 317
  • Luciani F, Champeval D, Herbette A, Denat L, Aylaj B, Martinozzi S, Ballotti R, Kemler R, Goding CR, De Vuyst F, et al (2011) Biological and mathematical modeling of melanocyte development. Development 138: 3943- 3954
  • Maelandsmo GM, Holm R, Nesland JM, Fodstad O, Flørenes VA (2003) Reduced β-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma. Clin Cancer Res 9: 3383- 3388
  • Massi D, Carli P, Franchi A, Santucci M (1999) Naevus-associated melanomas: cause or chance? Melanoma Res 9: 85- 91
  • Pasmanik-Chor M, Klein A, Nahmias C, Hoon DS, Ateh E, Tsarfaty G, Witz IP, Bryant JL, Sagi-Assif O, Couraud P, et al (2011) A molecular signature associated with human melanoma brain metastasis and spontaneous micrometastasis (8 assays). ebiacuk 1–1 Available at: http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-27980 [Accessed August 20, 2012]
  • Pham K, Milovanovic T, Barr RJ, Truong T, Holcombe RF (2003) Wnt ligand expression in malignant melanoma: pilot study indicating correlation with histopathological features. MP, Mol Pathol 56: 280- 285
  • Port F, Kuster M, Herr P, Furger E, Bänziger C, Hausmann G, Basler K (2008) Wingless secretion promotes and requires retromer-dependent cycling of Wntless. Nat Cell Biol 10: 178- 185
  • Pu P, Zhang Z, Kang C, Jiang R, Jia Z, Wang G, Jiang H (2009) Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth. Cancer Gene Ther 16: 351- 361
  • Reifenberger J, Knobbe CB, Wolter M, Blaschke B, Schulte KW, Pietsch T, Ruzicka T, Reifenberger G (2002) Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC. Int J Cancer 100: 549- 556
  • Reya T, Clevers H (2005) Wnt signalling in stem cells and cancer. Nature 434: 843- 850
  • Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, et al (2008) The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 1: 13
  • Ring DB, Johnson KW, Henriksen EJ, Nuss JM, Goff D, Kinnick TR, Ma ST, Reeder JW, Samuels I, Slabiak T, et al (2003) Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes 52: 588- 595
  • Rodriguez LG, Wu X, Guan J-L (2005) Wound-healing assay. Methods Mol Biol 294: 23- 29
  • Silhankova M, Port F, Harterink M, Basler K, Korswagen HC (2010) Wnt signalling requires MTM-6 and MTM-9 myotubularin lipid-phosphatase function in Wnt-producing cells. EMBO J 29: 4094- 4105
  • Smolle J, Kaddu S, Kerl H (1999) Non-random spatial association of melanoma and naevi-a morphometric analysis. Melanoma Res 9: 407- 412
  • Talantov D, Mazumder A, Yu JX, Briggs T, Backus YJJ, Atkins D, Wang Y (2005) Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res 11: 7234- 7242
  • Thorpe CJ, Schlesinger A, Carter JC, Bowerman B (1997) Wnt signaling polarizes an early C. elegans blastomere to distinguish endoderm from mesoderm. Cell 90: 695- 705
  • Urso C, Giannotti V, Reali UM, Giannotti B, Bondi R (1991) Spatial association of melanocytic naevus and melanoma. Melanoma Res 1: 245- 249
  • Valsesia A, Rimoldi D, Martinet D, Ibberson M, Benaglio P, Quadroni M, Waridel P, Gaillard M, Pidoux M, Rapin B, et al (2011) Network-guided analysis of genes with altered somatic copy number and gene expression reveals pathways commonly perturbed in metastatic melanoma. PLoS ONE 6: e18369
  • Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril M.-F, Ortiz Romero PL, Robert T, Balacescu O, et al Melanoma Group of the European Organization for Research and Treatment of Cancer (2006) Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst 98: 472- 482
  • Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Avril M-F, Robert T, Balacescu O, Eggermont AM, Lenoir G, et al (2007) Distant metastasis free survival of primary cutaneous melanoma is predicted by genome-wide expression profiling. pp 1- 1
  • Wu J, Saint-Jeannet J-P, Klein PS (2003) Wnt-frizzled signaling in neural crest formation. Trends Neurosci 26: 40- 45
  • Yang P-T, Lorenowicz MJ, Silhankova M, Coudreuse DYM, Betist MC, Korswagen HC (2008) Wnt signaling requires retromer-dependent recycling of MIG-14/Wntless in Wnt-producing cells. Dev Cell 14: 140- 147